Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymph Node Excision | 2 | 2005 | 1172 | 0.390 |
Why?
|
| Neoplastic Stem Cells | 4 | 2012 | 1390 | 0.390 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2005 | 1085 | 0.340 |
Why?
|
| Cell Transplantation | 1 | 2009 | 495 | 0.330 |
Why?
|
| Liver Diseases | 1 | 2009 | 1224 | 0.220 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2003 | 491 | 0.200 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2003 | 602 | 0.200 |
Why?
|
| Robotics | 1 | 2005 | 834 | 0.180 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2012 | 128 | 0.110 |
Why?
|
| Hypocalcemia | 1 | 2012 | 182 | 0.110 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2010 | 148 | 0.100 |
Why?
|
| Parathyroidectomy | 1 | 2012 | 233 | 0.100 |
Why?
|
| Mitochondria | 1 | 2003 | 3602 | 0.100 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2012 | 386 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 19153 | 0.090 |
Why?
|
| Neoplasms | 4 | 2012 | 19538 | 0.090 |
Why?
|
| Liver Regeneration | 1 | 2009 | 220 | 0.090 |
Why?
|
| Anti-HIV Agents | 1 | 2003 | 3955 | 0.090 |
Why?
|
| Mastectomy | 2 | 2005 | 1667 | 0.080 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 1974 | 0.070 |
Why?
|
| Zalcitabine | 1 | 2003 | 44 | 0.070 |
Why?
|
| Stavudine | 1 | 2003 | 95 | 0.070 |
Why?
|
| Axilla | 1 | 2005 | 509 | 0.060 |
Why?
|
| Baculoviridae | 1 | 2003 | 124 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2009 | 2913 | 0.060 |
Why?
|
| Chromans | 1 | 2003 | 131 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 318 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 2159 | 0.060 |
Why?
|
| Lamivudine | 1 | 2003 | 331 | 0.060 |
Why?
|
| Zidovudine | 1 | 2003 | 621 | 0.050 |
Why?
|
| Thiazolidinediones | 1 | 2003 | 495 | 0.050 |
Why?
|
| Protein Folding | 1 | 2003 | 883 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1858 | 0.050 |
Why?
|
| Epidermis | 1 | 2002 | 557 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 991 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 3018 | 0.040 |
Why?
|
| DNA Primers | 1 | 2003 | 3121 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2002 | 834 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 3983 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2003 | 2341 | 0.040 |
Why?
|
| Thiazoles | 1 | 2003 | 1559 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2003 | 4168 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2005 | 2068 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6499 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 14656 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 1826 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6464 | 0.030 |
Why?
|
| Animals | 6 | 2012 | 170849 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2003 | 19328 | 0.030 |
Why?
|
| Humans | 11 | 2012 | 686663 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 11265 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2012 | 11833 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 4686 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18495 | 0.020 |
Why?
|
| Mice | 4 | 2010 | 80803 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 15083 | 0.020 |
Why?
|
| Female | 6 | 2012 | 375459 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 786 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2010 | 690 | 0.020 |
Why?
|
| Middle Aged | 4 | 2012 | 216468 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2010 | 1416 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 164 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3789 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2002 | 345 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6669 | 0.010 |
Why?
|
| Transglutaminases | 1 | 2002 | 202 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2003 | 10088 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 3053 | 0.010 |
Why?
|
| Prognosis | 2 | 2010 | 28923 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2884 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 911 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 5391 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 955 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 2064 | 0.010 |
Why?
|
| Placebos | 1 | 2003 | 1791 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12734 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2002 | 2352 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2003 | 861 | 0.010 |
Why?
|
| Stem Cells | 1 | 2010 | 3612 | 0.010 |
Why?
|
| Fasting | 1 | 2003 | 1573 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 2238 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 2628 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 39737 | 0.010 |
Why?
|
| Adult | 2 | 2012 | 211400 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 1843 | 0.010 |
Why?
|
| Age Factors | 1 | 2012 | 19295 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 20496 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13204 | 0.010 |
Why?
|
| Aged | 1 | 2005 | 162271 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 13729 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2012 | 24351 | 0.010 |
Why?
|
| Insulin | 1 | 2003 | 6521 | 0.010 |
Why?
|
| Male | 3 | 2012 | 352465 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 2002 | 20620 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 67320 | 0.000 |
Why?
|
| Time Factors | 1 | 2003 | 42271 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_